ESR1 and breast cancer: TNBC is negative for the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2), and therefore does not respond to the targeted therapies that have largely explained the improvements in breast cancer outcomes in recent decades.21, 22